Product fact sheet
Hooga ULTRA750 Technical Profile
Hooga ULTRA750 specifications from the 2025 manufacturer manual, including dimensions, four wavelengths, 150 LEDs, beam angle, pulse controls and the limits of manufacturer-only output data.
A 150-LED four-wavelength ULTRA panel with adjustable pulse controls and a 20.4-inch manual-listed height.
mid-size four-wavelength comparisons, buyers wanting a current primary manual
buyers requiring independent irradiance, buyers who want clinical ranking from hardware features
Key tradeoff: Detailed controls and hardware documentation, but no normalized independent optical test is in the record.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
Published hardware specifications
The 2025 ULTRA manual lists the ULTRA750 at 20.4 × 8.6 × 2.5 inches, with 150 LEDs, 630 / 660 / 810 / 850 nm output bands and a 60° beam angle. The manual also documents pulse controls and AC 85–265 V input.
These are manufacturer specifications. They describe the device configuration, not treatment effectiveness.
Rated power and output-power fields
The specification table gives 750 W rated power and a separate 248.2 W output-power field.
Those labels describe different quantities and should remain separate. Neither number should be converted into a clinical-performance score or compared with another manufacturer’s differently defined “power” figure without a common measurement method.
Independent measurement gap
No independent common-protocol irradiance result is normalized for this device in the current record. Wall draw, optical output, heat, noise and beam uniformity have not been measured by the publication under a shared cross-brand protocol.
That leaves the manual as the main source for hardware specifications. Manufacturer coverage or irradiance charts should be treated as manufacturer evidence unless independently reproduced.
For the difference between wavelength, irradiance, radiant power and electrical draw, see How to Read Red Light Device Specifications.
Technical specifications
Published specs and what they mean
Physical
- Dimensions
- 20.4 × 8.6 × 2.5 in Basis: Manufacturer manual 2025 ULTRA manual. Source: Hooga ULTRA Series User Manual (PDF)
Optical
- Wavelengths
- 630 / 660 / 810 / 850 nm Basis: Manufacturer manual 2025 ULTRA manual. Source: Hooga ULTRA Series User Manual (PDF)
- LED quantity
- 150 LEDs Basis: Manufacturer manual 2025 ULTRA manual. Source: Hooga ULTRA Series User Manual (PDF)
- Rated power
- 750 W Basis: Manufacturer manual Manufacturer rated-power label. Source: Hooga ULTRA Series User Manual (PDF)
- Beam angle
- 60° Basis: Manufacturer manual 2025 ULTRA manual. Source: Hooga ULTRA Series User Manual (PDF)
Electrical
- Manual-listed output power
- 248.2 W Basis: Manufacturer manual Preserves the manual's field wording; not treated as an independent measurement. Source: Hooga ULTRA Series User Manual (PDF)
- Power input
- AC 85–265 V Basis: Manufacturer manual 2025 ULTRA manual. Source: Hooga ULTRA Series User Manual (PDF)
Controls
- Pulse control
- 1–100 Hz adjustable; manufacturer presets described Basis: Manufacturer manual 2025 ULTRA manual. Source: Hooga ULTRA Series User Manual (PDF)
What the current record does not establish
- No independent common-protocol optical measurement is normalized.
- Manufacturer irradiance/coverage charts remain manufacturer evidence.
- No Homeapotherapy hands-on testing exists.
A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Dose and irradiance context
What the output number means over time
Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.
No comparable independent average irradiance is normalized
This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.
What this calculation still cannot tell you
- whether this is an effective dose for any condition;
- how irradiance changes at a different distance or across curved anatomy;
- how much energy reaches tissue below the surface;
- whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
- whether peak irradiance would produce the same area exposure as the average value shown here.
Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.
Clinical evidence context
Where these wavelengths overlap with human research
Published device wavelengths: 630 / 660 / 810 / 850 nm.
This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.
Research areas worth checking
- Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
- Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
- Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
- Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
- Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
- Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
- See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.
Do not infer from wavelength overlap
- that this device is clinically proven for the linked condition;
- that more wavelengths are better;
- that the highest published irradiance is the best dose;
- that an open wound should be treated with a consumer device without appropriate wound assessment.
For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.
Safety first
What should make you slow down?
Use the current ULTRA-series manual for eye protection, electrical operation and pulse settings. Hardware controls are not efficacy claims.
- The manual contains eye-exposure and electrical-safety warnings.
- Manufacturer coverage and irradiance charts remain manufacturer evidence unless independently reproduced.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- Hooga ULTRA Series User ManualHooga · Manufacturer manual · PDF · retrieved 2026-08-11
- Hooga Quality & Certifications: What We Can VerifyHooga · Manufacturer · retrieved 2026-08-10
- Photobiomodulation (PBM) Devices - Premarket Notification [510(k)] SubmissionsU.S. Food and Drug Administration · Regulatory · retrieved 2026-08-10